Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
January 31 2023 - 3:05PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced it will report
fourth quarter and fiscal year 2022 financial results before market
opening on Thursday, February 9, 2023. The Company will host a
conference call and webcast at 8:30 a.m. Eastern Standard Time to
discuss the results and current business trends.
To listen to the webcast, investors can go to
https://ir.bruker.com and click on the “Q4 2022 Earnings Webcast”
hyperlink in the “Events & Presentations” section. A slide
presentation will be referenced during the webcast and will be
posted to the Company’s website shortly before the webcast
begins.
Investors can also listen to the earnings webcast via telephone
by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702
(international) and referencing “Bruker’s Fourth Quarter 2022
Earnings Conference Call”.
Bruker is enabling investors to pre-register for the earnings
conference call so that they can expedite their entry into the call
and avoid the need to wait for a live operator. In order to
pre-register for the call, investors can visit
https://dpregister.com/sreg/10175231/f5bb11abd5 and enter
their contact information. Investors will then be issued a
personalized phone number and PIN to dial into the live conference
call. Individuals can pre-register any time prior to the start of
the conference call on February 9.
A telephone replay of the conference call will be available by
dialing 1-877-344-7529 (U.S. toll free) or +1-412-317-0088
(international) and entering replay access code: 3734516. The
replay will be available beginning one hour after the end of the
conference call through March 9, 2023.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular, and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity, and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230131005941/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 663-3660 x1479 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024